Page last updated: 2024-12-05
isopropyl iodide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
isopropyl iodide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6362 |
SCHEMBL ID | 5555 |
MeSH ID | M0047836 |
Synonyms (48)
Synonym |
---|
c3h7i |
isopropyl iodide |
sec-propyl iodide |
2-jodpropan [czech] |
einecs 200-859-3 |
ai3-28595 |
2-propyl iodide |
inchi=1/c3h7i/c1-3(2)4/h3h,1-2h |
propane, 2-iodo- |
2-iodopropane |
2-iodo-propane |
2-iodopropane, contains copper as stabilizer, 99% |
AKOS000118757 |
75-30-9 |
I0069 |
2-iodanylpropane |
A838375 |
BBL012222 |
STL163563 |
2-iodopropane over cu |
FT-0642464 |
2-jodpropan |
67k05opz0e , |
unii-67k05opz0e |
FT-0612687 |
1-methylethyl iodide |
isopropyl iodide [mi] |
SCHEMBL5555 |
isopropyliodide |
i-pri |
isopropyl-iodide |
ipri |
i-propyl iodide |
2iodopropane |
iso-propyl iodide |
2-iodo propane |
DTXSID4058788 |
propane, 2-iodo-, |
iso-c3h7i |
isopropyl iodine |
STR01941 |
mfcd00001071 |
J-802231 |
F2190-0173 |
isopropyljodid |
Q209415 |
2-iodopropane (stabilized with copper) |
EN300-19281 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 45.26
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (45.26) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |